ERBB2 and breast neoplasm: Intriguingly, MCF7-TamC3 cells also exhibit characteristics that resemble the luminal B-ERBB2+ breast tumor subtype, like the increased expression of ERBB2 and the increased sensitivity to monoclonal ERBB2-targeting antibody Trastuzumab in vitro.